Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
27,094,118
-
Total 13F shares
-
5,352,153
-
Share change
-
+1,192,072
-
Total reported value
-
$28,835,055
-
Put/Call ratio
-
19%
-
Price per share
-
$5.39
-
Number of holders
-
66
-
Value change
-
+$6,023,573
-
Number of buys
-
42
-
Number of sells
-
14
Institutional Holders of Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB) as of Q3 2024
As of 30 Sep 2024,
Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB) was held by
66 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,352,153 shares.
The largest 10 holders included
BlackRock, Inc., Praetorian PR LLC, VANGUARD GROUP INC, Raymond James Financial Services Advisors, Inc., GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, MILLENNIUM MANAGEMENT LLC, Rhenman & Partners Asset Management AB, MAI Capital Management, and DEUTSCHE BANK AG\.
This page lists
65
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.